Characteristics | N | Adherence (%)a | P value |
---|---|---|---|
Overall | 121 | 46.4 (39.3, 54.5) | – |
Type of prediction study | |||
Model development (type “D”) | 93 | 44.8 (39.3, 51.8) | < 0.001§ |
External validation (type “V”) | 10 | 45.7 (35.6, 65.7) | |
Incremental value (type “IV”) | 6 | 49.2 (45.9, 53.3) | |
Development and external validation (type “D + V”) | 12 | 68.1 (53.4, 78.2) | |
Publication year | |||
2011–2015 | 44 | 43.9 (39.3, 55.9) | 0.103* |
2016–2020 | 77 | 46.7 (37.3, 55.9) | |
Involvement of any epidemiologist or statistician | |||
No | 97 | 46.4 (39.3, 53.5) | 0.630* |
Yes | 24 | 45.2 (39.5, 58.7) | |
Number of study sites | |||
Monocenter | 54 | 44.4 (39.3, 53.2) | 0.277* |
Multicenter | 67 | 46.7 (39.3, 55.2) | |
Prospective design | |||
No | 46 | 46.4 (40.4, 56.8) | 0.665* |
Yes | 75 | 46.4 (37.3, 53.1) |